Overview

NCI Definition [1]:
A third generation, cationic, lipophilic, manganese (Mn) and porphyrin-based mimetic of the human mitochondrial manganese superoxide dismutase (MnSOD), with antioxidant and potential chemoprotective activities. Upon administration, MnSOD mimetic BMX-001 is internalized by cells and mimics the activity of MnSOD by scavenging reactive oxygen species (ROS), such as superoxide anion, hydrogen peroxide, and hydroxyl radical. This prevents oxidative damage to macromolecules such as DNA and minimizes oxygen free radical-related chemotoxicity in normal tissues. This agent was designed to be more lipophilic and less toxic than first and second generation Mn-porphyrin mimetics.

Bmx-001 has been investigated in 1 clinical trial, of which 1 is open and 0 are closed. Of the trial investigating bmx-001, 1 is phase 1/phase 2 (1 open).

Breast carcinoma, melanoma, and non-small cell lung carcinoma are the most common diseases being investigated in bmx-001 clinical trials [2].

Drug Details

Synonyms [2]:
mntnbuoe-3-pyp 5+, manganese butoxyethyl pyridyl porphyrin; mn(iii) meso-tetrakis(n-n-butoxyethylpyridinium-2-yl)porphyrin (sy); mntnbuoe-3-pyp 5+, mnsod mimetic bmx-001, manganese(5+), ((2,2',2'',2'''-(21h,23h-porphine-5,10,15,20-tetrayl-kappan21,kappan22,kappan23,kappan24)tetrakis(1-(2-butoxyethyl)pyridiniumato))(2-))-, chloride (1:5), (sp-4-1)-, mn(iii) meso-tetrakis(n-n-butoxyethylpyridinium-2-yl)porphyrin, manganese(5+), ((2,2',2'',2'''-(21h,23h-porphine-5,10,15,20-tetrayl-kappan21,kappan22,kappan23,kappan24)tetrakis(1-(2-butoxyethyl)pyridiniumato))(2-))-, chloride (1:5), (sp-4-1)-, manganese (iii) ortho n-butoxyethylpyridylporphyrin, mnsod mimetic bmx-001, mntnbuoe-2-pyp(5+), mitochondrial manganese superoxide dismutatse mimetic bmx-001, 1379783-91-1, manganese butoxyethyl pyridyl porphyrin, manganese (iii) ortho n-butoxyethylpyridylporphyrin, mitochondrial manganese superoxide dismutatse mimetic bmx-001
Drug Target(s) [2]:
SOD2
NCIT ID [1]:
C125666

References

1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/. [2018-07-30] [2018-08-02].

2. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.